Your browser doesn't support javascript.
loading
Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor Ameliorate Metabolic Disorder and Obesity Induced Cardiomyocyte Injury and Mitochondrial Remodeling.
Jhuo, Shih-Jie; Lin, Yi-Hsiung; Liu, I-Hsin; Lin, Tsung-Hsien; Wu, Bin-Nan; Lee, Kun-Tai; Lai, Wen-Ter.
Afiliação
  • Jhuo SJ; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
  • Lin YH; Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
  • Liu IH; Department of Internal Medicine, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
  • Lin TH; Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
  • Wu BN; Lipid Science and Aging Research Center, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
  • Lee KT; Center for Lipid Biosciences, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
  • Lai WT; Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
Int J Mol Sci ; 24(7)2023 Apr 06.
Article em En | MEDLINE | ID: mdl-37047815

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article